MindMaze Therapeutics Holding SA (MMTX.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: -51.56%; 2025 (actual)
ROA: -38.38%; 2025 (actual)
Gross Margin: 92.06%; 2025 (actual)
Net Margin: -
Total Assets: CHF 51,530.00K; 2025 (actual)
Net Income: -CHF 9,906.00K; 2025 (actual)
Valuation: CHF 322,988.12K; 2025 (actual)
Stock Price: CHF 1.90; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-51.56%	-30.82%	-53.13%	-136.29%	347.02%	80.65%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	-38.38%	-21.86%	-27.31%	-29.3%	-31.16%	-32.28%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Gross Margin	92.06%	92.06%	92.06%

Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for MindMaze Therapeutics Holding SA? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	CHF 51,530.00K	CHF 42,143.48K	CHF 44,229.24K	CHF 45,993.72K	CHF 47,589.37K	CHF 48,651.41K
Sector average	CHF 6,583,664.69K	CHF 7,029,775.91K	CHF 7,875,113.17K	CHF 8,842,325.96K	CHF 9,880,548.85K	CHF 10,888,357.41K

Net Income	-CHF 9,906.00K	-CHF 10,239.58K	-CHF 11,795.79K	-CHF 13,216.80K	-CHF 14,581.58K	-CHF 15,533.61K
Sector average	CHF 509,037.80K	CHF 497,738.03K	CHF 567,206.48K	CHF 655,953.18K	CHF 738,044.20K	CHF 795,142.15K

Valuation	CHF 322,988.12K	CHF 333,864.67K	CHF 384,605.37K	CHF 430,937.80K	CHF 475,436.88K	CHF 506,478.08K
Sector average	CHF 12,182,569.70K	CHF 13,169,956.24K	CHF 13,319,586.58K	CHF 13,502,659.68K	CHF 13,728,881.51K	CHF 13,908,079.25K

Stock Price	CHF 1.90	CHF 1.96	CHF 2.26	CHF 2.54	CHF 2.80	CHF 2.98
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32